Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-29 6:01 pm Sale | 2024-12-31 | 13G | Hydrofarm Holdings Group, Inc. HYFM | Michael Rapoport | 1,728,394 3.700% | -600,326 (-25.78%) | Filing History |
| 2024-03-28 08:00 am Purchase | 2024-03-26 | 13G | Hydrofarm Holdings Group, Inc. HYFM | Michael Rapoport | 2,328,720 5.100% | 616,760 (+36.03%) | Filing History |
| 2022-02-14 1:22 pm Purchase | 2021-12-31 | 13G | Immunome, Inc. IMNM | Michael Rapoport | 1,181,575 9.600% | 131,086 (+12.48%) | Filing History |
| 2021-02-10 4:40 pm Purchase | 2020-12-31 | 13G | Immunome, Inc. IMNM | Michael Rapoport | 1,050,489 9.970% | 1,050,489 (New Position) | Filing History |
| 2021-02-05 8:34 pm Sale | 2020-12-31 | 13G | Zynerba Pharmaceuticals, Inc. ZYNE | Michael Rapoport | 0 0.000% | -1,490,000 (Position Closed) | Filing History |
| 2021-01-07 4:07 pm Purchase | 2020-12-31 | 13G | Hydrofarm Holdings Group, Inc. HYFM | Michael Rapoport | 1,711,960 5.200% | 1,711,960 (New Position) | Filing History |